Lara A Ray (Lara Ray)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 57

Top Topics

Systematic Review

Alcohol Use Disorder

Magnetic Resonance

Top Venues

Alcoholism, clinical and experimental research

Addiction biology

Alcohol and alcoholism (Oxford, Oxfordshire)

Alcohol, clinical & experimental research

This page only lists publications with an associated author ORCID identifier.

Publications

Erica N Grodin, Kaitlin R McManus, Lara A Ray
Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder. Addiction biology 29 (8) (2024)
Annabel Kady, Erica N Grodin, Lara A Ray
Characterizing reward and relief/habit drinking profiles in a study of naltrexone, varenicline, and placebo. Alcohol and alcoholism (Oxford, Oxfordshire) 59 (4) (2024)
Wave-Ananda Baskerville, Erica N Grodin, Lara A Ray
Influence of sleep quality on lapse to alcohol use during a quit attempt. Alcohol and alcoholism (Oxford, Oxfordshire) 59 (2) (2024)
Erica N Grodin, Kaitlin R McManus, Lara A Ray
Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder. Addiction biology 29 (8) (2024)
Erica N Grodin, Kaitlin R McManus, Lara A Ray
Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder. Addiction biology 29 (8) (2024)
Dylan E Kirsch, Erica N Grodin, Steven J Nieto, Annabel Kady, Lara A Ray
Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Erica N Grodin, Annabel Kady, Lara A Ray
The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventions. Alcohol, clinical & experimental research 48 (3) (2024)
Erica N Grodin, Annabel Kady, Lara A Ray
The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventions. Alcohol, clinical & experimental research (2024)
Erica N Grodin, Elizabeth M Burnette, Crystal Rodriguez, Jennifer A Fulcher, Lara A Ray
The gut microbiome in alcohol use disorder and alcohol-associated liver disease: A systematic review of clinical studies. Alcohol, clinical & experimental research (2024)
Erica N Grodin, Annabel Kady, Lara A Ray
The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventions. Alcohol, clinical & experimental research 48 (3) (2024)
Annabel Kady, Erica N Grodin, Lara A Ray
Characterizing reward and relief/habit drinking profiles in a study of naltrexone, varenicline, and placebo. Alcohol and alcoholism (Oxford, Oxfordshire) 59 (4) (2024)
Erica N Grodin, Elizabeth M Burnette, Crystal Rodriguez, Jennifer A Fulcher, Lara A Ray
The gut microbiome in alcohol use disorder and alcohol-associated liver disease: A systematic review of clinical studies. Alcohol, clinical & experimental research 48 (7) (2024)
Erica N Grodin, Annabel Kady, Lara A Ray
The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventions. Alcohol, clinical & experimental research 48 (3) (2024)
Andras H Leko, Lara A Ray, Lorenzo Leggio
The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity toward the development of new medications? Alcoholism, clinical and experimental research (2023)
András H Lékó, Lara A Ray, Lorenzo Leggio
The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications? Alcoholism, clinical and experimental research (2023)
Lara A Ray, Steven J Nieto, Lindsay R Meredith, Elizabeth Burnette, Suzanna Donato, Molly Magill, Han Du
Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study. Psychopharmacology (2023)
Lara A Ray, Wave-Ananda Baskerville, Steven J Nieto, Erica Grodin, Craig Enders, Annabel Kady, Lindsay Meredith, Artha Gillis, Adam Leventhal, Diana Ho, Karen Miotto
A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial. Psychopharmacology (2023)
Lindsay R Meredith, Elizabeth M Burnette, Steven J Nieto, Han Du, Suzanna Donato, Erica N Grodin, ReJoyce Green, Molly Magill, Wave-Ananda Baskerville, Lara A Ray
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology. Alcohol (Hanover, York County, Pa.) (2023)
ReJoyce Green, Daniel James Olan Roche, Lara A Ray
The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers. Alcohol and alcoholism (Oxford, Oxfordshire) 57 (5) (2022)
Steven J Nieto, Craig K Enders, Katie A Witkiewitz, Stephanie S O'Malley, Lara A Ray
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcoholism, clinical and experimental research 46 (12) (2022)
Adam M Leventhal, Junhan Cho, Lara A Ray, Rosalie Liccardo Pacula, Brian P Lee, Norah Terrault, Eric Pedersen, Jungeun Olivia Lee, Jordan P Davis, Haomiao Jin, Jimi Huh, John P Wilson, Reid C Whaley
Alcohol use trajectories among U.S. adults during the first 42 weeks of the COVID-19 pandemic. Alcoholism, clinical and experimental research 46 (6) (2022)
Steven J Nieto, Craig K Enders, Katie A Witkiewitz, Stephanie S O'Malley, Lara A Ray
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcoholism, clinical and experimental research (2022)
Suzanna Donato, Steven J Nieto, Lara A Ray
The Brief Alcohol Use Disorder Severity Scale: An Initial Validation Evaluation. Alcohol and alcoholism (Oxford, Oxfordshire) 57 (6) (2022)
Steven J Nieto, Craig K Enders, Katie A Witkiewitz, Stephanie S O'Malley, Lara A Ray
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcoholism, clinical and experimental research 46 (12) (2022)
Alexandra Venegas, Lara A Ray
Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach. Experimental and clinical psychopharmacology (2022)
Erica N Grodin, Steven J Nieto, Lindsay R Meredith, Elizabeth M Burnette, Joseph O'Neill, Jeffry Alger, Edythe D London, Karen Miotto, Christopher J Evans, Michael R Irwin, Lara A Ray
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addiction biology 27 (4) (2022)
Steven J Nieto, Erica N Grodin, Diana Ho, Wave-Ananda Baskerville, Lara A Ray
Moderators of subjective response to alcohol in the human laboratory. Alcoholism, clinical and experimental research 46 (3) (2022)
Steven J Nieto, Erica N Grodin, Elizabeth M Burnette, Catherine M Cahill, Lara A Ray
Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder. Alcohol and alcoholism (Oxford, Oxfordshire) 57 (6) (2022)
Erica N Grodin, Lindsay R Meredith, Elizabeth M Burnette, Karen Miotto, Michael R Irwin, Lara A Ray
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. The American journal of drug and alcohol abuse (2022)
Steven J Nieto, Craig K Enders, Katie A Witkiewitz, Stephanie S O'Malley, Lara A Ray
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcoholism, clinical and experimental research 46 (12) (2022)
Lindsay R Meredith, Erica N Grodin, Amanda K Montoya, Robert Miranda, Lindsay M Squeglia, Brandon Towns, Christopher Evans, Lara A Ray
The effect of neuroimmune modulation on subjective response to alcohol in the natural environment. Alcoholism, clinical and experimental research 46 (5) (2022)
Suzanna Donato, ReJoyce Green, Lara A Ray
Alcohol use disorder severity moderates clinical response to varenicline. Alcoholism, clinical and experimental research 45 (9) (2021)
Steven J Nieto, Wave Baskerville, Suzanna Donato, Spencer Bujarski, Lara A Ray
Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use. The American journal of drug and alcohol abuse 47 (5) (2021)
ReJoyce Green, Han Du, Erica N Grodin, Steven J Nieto, Spencer Bujarski, Daniel James Olan Roche, Lara A Ray
A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol. Alcoholism, clinical and experimental research 45 (7) (2021)
Steven J Nieto, Erica N Grodin, Claudia G Aguirre, Juan Luis Romero Sosa, Lara A Ray
Translational opportunities in animal and human models to study alcohol use disorder. Translational psychiatry 11 (1) (2021)
Elizabeth M Burnette, Lara A Ray, Michael R Irwin, Erica N Grodin
Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder. Alcoholism, clinical and experimental research 45 (10) (2021)
Alexandra Venegas, Suzanna Donato, Lindsay R Meredith, Lara A Ray
Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement. The American journal of drug and alcohol abuse (2021)
Lindsay R Meredith, Erica N Grodin, Mitchell P Karno, Amanda K Montoya, James MacKillop, Aaron C Lim, Lara A Ray
Preliminary study of alcohol problem severity and response to brief intervention. Addiction science & clinical practice 16 (1) (2021)
Erica N Grodin, Spencer Bujarski, Brandon Towns, Elizabeth Burnette, Steven J Nieto, Aaron Lim, Johnny Lin, Karen Miotto, Artha Gillis, Michael R Irwin, Christopher Evans, Lara A Ray
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational psychiatry 11 (1) (2021)
Elizabeth M Burnette, Erica N Grodin, Joseph P Schacht, Lara A Ray
Clinical and Neural Correlates of Reward and Relief Drinking. Alcoholism, clinical and experimental research 45 (1) (2020)
Alexandra Venegas, Lindsay R Meredith, ReJoyce Green, Ziva D Cooper, Lara A Ray
Sex-dependent effects of alcohol administration on the urge to use cannabis. Experimental and clinical psychopharmacology (2020)
Mariel S Bello, Madalyn M Liautaud, Julianne T De La Cerda, Raina D Pang, Lara A Ray, Jasjit A Ahluwalia, Adam M Leventhal
Association of frequency of perceived exposure to discrimination with tobacco withdrawal symptoms and smoking lapse behavior in African Americans. Addiction (Abingdon, England) 116 (4) (2020)
Lara A Ray, Erica N Grodin, Lorenzo Leggio, Anita J Bechtholt, Howard Becker, Sarah W Feldstein Ewing, James David Jentsch, Andrea C King, Barbara J Mason, Stephanie O'Malley, James M MacKillop, Markus Heilig, George F Koob
The future of translational research on alcohol use disorder. Addiction biology 26 (2) (2020)
Erica N Grodin, Amanda Kay Montoya, Spencer Bujarski, Lara A Ray
Modeling motivation for alcohol in humans using traditional and machine learning approaches. Addiction biology 26 (3) (2020)
Lara A Ray, Han Du, ReJoyce Green, Daniel J O Roche, Spencer Bujarski
Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (3) (2020)
Steven J Nieto, ReJoyce Green, James M MacKillop, Lara A Ray
Intravenous Alcohol Administration Selectively Decreases Rate of Change in Elasticity of Demand in Individuals With Alcohol Use Disorder. Alcoholism, clinical and experimental research 44 (11) (2020)
Erica N Grodin, Lara A Ray, James MacKillop, Aaron C Lim, Mitchell P Karno
Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcoholism, clinical and experimental research 43 (2) (2019)
ReJoyce Green, Erica N Grodin, Aaron C Lim, Alexandra Venegas, Spencer Bujarski, Jennifer Krull, Lara A Ray
The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self-Administration in the Human Laboratory. Alcoholism, clinical and experimental research 43 (5) (2019)
Lara A Ray, ReJoyce Green, Daniel J O Roche, Molly Magill, Spencer Bujarski
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis. Addiction biology 24 (6) (2019)
Erica N Grodin, Lara A Ray
The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review. Alcoholism, clinical and experimental research 43 (10) (2019)
Clarissa I Cortland, Jenessa R Shapiro, Iris Y Guzman, Lara A Ray
The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology. Addiction (Abingdon, England) 114 (10) (2019)
Molly Magill, Lara A Ray, Brian Kiluk, Ariel Hoadley, Michael Bernstein, J Scott Tonigan, Kathleen Carroll
A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of consulting and clinical psychology 87 (12) (2019)
Brian D Kiluk, Lara A Ray, Justin Walthers, Michael Bernstein, Jeffery S Tonigan, Molly Magill
Technology-Delivered Cognitive-Behavioral Interventions for Alcohol Use: A Meta-Analysis. Alcoholism, clinical and experimental research 43 (11) (2019)
Daniel E Falk, Megan L Ryan, Joanne B Fertig, Eric G Devine, Ricardo Cruz, E Sherwood Brown, Heather Burns, Ihsan M Salloum, D Jeffrey Newport, John Mendelson, Gantt Galloway, Kyle Kampman, Catherine Brooks, Alan I Green, Mary F Brunette, Richard N Rosenthal, Kelly E Dunn, Eric C Strain, Lara A Ray, Steven Shoptaw, Nassima Ait-Daoud Tiouririne, Erik W Gunderson, Janet Ransom, Charles Scott, Lorenzo Leggio, Steven Caras, Barbara J Mason, Raye Z Litten, null null
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety. Alcoholism, clinical and experimental research 43 (1) (2018)
Lara A Ray, Aaron C Lim, Steven Shoptaw
What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'. Addiction (Abingdon, England) 114 (1) (2018)
Vincent C Allen, Lara A Ray, Hector F Myers
Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men. Alcoholism, clinical and experimental research (2018)
Lara A Ray, Spencer Bujarski, Daniel James Olan Roche, Molly Magill
Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder. Alcoholism, clinical and experimental research 42 (9) (2018)